Tony W Ho Insider Trading $CRSP CRISPR Therapeutics AG

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Tony W Ho.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Tony W Ho. Tony W Ho is Executive VP, Head of R&D in CRISPR Therapeutics AG ($CRSP) and See Remarks in CRISPR Therapeutics AG ($CRSP) and Director in iTeos Therapeutics, Inc. ($ITOS).

Tony W Ho in CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Tony W Ho: Executive VP, Head of R&D, See Remarks
Holdings: 40,445 shares
Current Value: $637,009
Latest Transaction: Mar 12 2021
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Tony W Ho in CRISPR Therapeutics AG

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CRSP, ITOS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Option Exercise	A	0.00	9,000	0	9,000
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Option Exercise	A	133.88	23,334	3,123,956	23,334
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Payment of Exercise	F	124.15	2,141	265,805	38,304	40.4 K to 38.3 K (-5.29 %)
Mar 12 2021	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Buy	M	0.00	4,583	0	40,445	35.9 K to 40.4 K (+12.78 %)
Mar 09 2021	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Payment of Exercise	F	114.65	1,585	181,720	35,862	37.4 K to 35.9 K (-4.23 %)
Mar 09 2021	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Buy	M	0.00	3,333	0	37,447	34.1 K to 37.4 K (+9.77 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Option Exercise	M	16.90	23,551	398,012	236,449
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	150.61	2,951	444,450	33,964	36.9 K to 34 K (-7.99 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	149.73	5,000	748,650	36,915	41.9 K to 36.9 K (-11.93 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	148.38	8,400	1,246,392	41,915	50.3 K to 41.9 K (-16.69 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	147.05	1,400	205,870	50,315	51.7 K to 50.3 K (-2.71 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	152.41	500	76,205	51,715	52.2 K to 51.7 K (-0.96 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	151.58	1,100	166,738	52,215	53.3 K to 52.2 K (-2.06 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	150.16	1,600	240,256	53,315	54.9 K to 53.3 K (-2.91 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	149.18	900	134,262	54,915	55.8 K to 54.9 K (-1.61 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	148.11	1,700	251,787	55,815	57.5 K to 55.8 K (-2.96 %)
Dec 22 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Buy	M	16.90	23,551	398,012	57,515	34 K to 57.5 K (+69.34 %)
Oct 06 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Option Exercise	A	86.75	16,666	1,445,776	16,666
Jun 24 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	75.20	6,929	521,061	33,747	40.7 K to 33.7 K (-17.03 %)
Jun 24 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	70.14	229	16,062	40,676	40.9 K to 40.7 K (-0.56 %)
May 27 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	70.14	6,100	427,854	40,905	47 K to 40.9 K (-12.98 %)
May 27 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Sell	S	70.05	600	42,030	47,005	47.6 K to 47 K (-1.26 %)
Mar 09 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Payment of Exercise	F	52.64	1,563	82,276	47,605	49.2 K to 47.6 K (-3.18 %)
Mar 09 2020	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Buy	M	0.00	3,333	0	49,168	45.8 K to 49.2 K (+7.27 %)
Dec 05 2019	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Option Exercise	A	0.00	40,000	0	40,000
Aug 05 2019	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Option Exercise	M	0.00	37,500	0	0
Aug 05 2019	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Payment of Exercise	F	52.56	14,534	763,907	45,835	60.4 K to 45.8 K (-24.08 %)
Aug 05 2019	CRSP	CRISPR Therapeutic ...	Ho Tony W	Executive VP, Head ...	Buy	M	0.00	37,500	0	60,369	22.9 K to 60.4 K (+163.98 %)
Mar 07 2019	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Option Exercise	A	40.87	75,000	3,065,250	75,000
Mar 07 2019	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Grant	A	40.87	10,000	408,700	32,869	22.9 K to 32.9 K (+43.73 %)
Aug 03 2018	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Option Exercise	M	0.00	37,500	0	37,500
Aug 03 2018	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Payment of Exercise	F	48.43	14,631	708,579	22,869	37.5 K to 22.9 K (-39.02 %)
Aug 03 2018	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Buy	M	0.00	37,500	0	37,500	0 to 37.5 K
Jun 15 2018	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Option Exercise	A	59.31	43,000	2,550,330	43,000
Jun 15 2018	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Option Exercise	A	59.31	43,000	2,550,330	43,000
Mar 09 2018	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Option Exercise	A	51.49	53,000	2,728,970	53,000
Aug 02 2017	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Option Exercise	A	16.90	260,000	4,394,000	260,000
Aug 02 2017	CRSP	CRISPR Therapeutic ...	Ho Tony W	See Remarks	Option Exercise	A	0.00	75,000	0	75,000

Page: 1